Literature DB >> 14742218

Genetic environment and transcription of ampC in an Acinetobacter baumannii clinical isolate.

Heidi Segal1, E C Nelson, B Gay Elisha.   

Abstract

An ampC gene was cloned from a clinical isolate of Acinetobacter baumannii (strain RAN). DNA sequencing and primer extension studies showed that ampC is transcribed from a promoter contained within a putative insertion sequence element which has been found to abut several different genes in Acinetobacter spp.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14742218      PMCID: PMC321557          DOI: 10.1128/AAC.48.2.612-614.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Biochemical characterization of chromosomal cephalosporinases from isolates belonging to the Acinetobacter baumannii complex.

Authors:  S López-Hernández; T Alarcón; M López-Brea
Journal:  Clin Microbiol Infect       Date:  2001-04       Impact factor: 8.067

2.  Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC beta-lactamase in Acinetobacter baumannii.

Authors:  G Bou; J Martínez-Beltrán
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

Review 3.  RNA polymerase-promoter interactions: the comings and goings of RNA polymerase.

Authors:  P L deHaseth; M L Zupancic; M T Record
Journal:  J Bacteriol       Date:  1998-06       Impact factor: 3.490

4.  Prolonged incubation in calcium chloride improves the competence of Escherichia coli cells.

Authors:  M Dagert; S D Ehrlich
Journal:  Gene       Date:  1979-05       Impact factor: 3.688

5.  Chromosomal integration of a cephalosporinase gene from Acinetobacter baumannii into Oligella urethralis as a source of acquired resistance to beta-lactams.

Authors:  Hedi Mammeri; Laurent Poirel; Nicole Mangeney; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

6.  Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001.

Authors:  James A Karlowsky; Deborah C Draghi; Mark E Jones; Clyde Thornsberry; Ian R Friedland; Daniel F Sahm
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

7.  Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.

Authors:  C Yanisch-Perron; J Vieira; J Messing
Journal:  Gene       Date:  1985       Impact factor: 3.688

8.  Natural transformation in mesophilic and thermophilic bacteria: identification and characterization of novel, closely related competence genes in Acinetobacter sp. strain BD413 and Thermus thermophilus HB27.

Authors:  A Friedrich; T Hartsch; B Averhoff
Journal:  Appl Environ Microbiol       Date:  2001-07       Impact factor: 4.792

9.  Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936).

Authors:  Caroline J Henwood; Tess Gatward; Marina Warner; Dorothy James; Mark W Stockdale; Richard P Spence; Kevin J Towner; David M Livermore; Neil Woodford
Journal:  J Antimicrob Chemother       Date:  2002-03       Impact factor: 5.790

10.  AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains.

Authors:  Stéphane Corvec; Nathalie Caroff; Eric Espaze; Cécile Giraudeau; Henri Drugeon; Alain Reynaud
Journal:  J Antimicrob Chemother       Date:  2003-09-01       Impact factor: 5.790

View more
  29 in total

Review 1.  ISCR elements: novel gene-capturing systems of the 21st century?

Authors:  Mark A Toleman; Peter M Bennett; Timothy R Walsh
Journal:  Microbiol Mol Biol Rev       Date:  2006-06       Impact factor: 11.056

Review 2.  Modes and modulations of antibiotic resistance gene expression.

Authors:  Florence Depardieu; Isabelle Podglajen; Roland Leclercq; Ekkehard Collatz; Patrice Courvalin
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

3.  Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-23 in Acinetobacter baumannii.

Authors:  Stéphane Corvec; Laurent Poirel; Thierry Naas; Henri Drugeon; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

4.  OXA-58, a novel class D {beta}-lactamase involved in resistance to carbapenems in Acinetobacter baumannii.

Authors:  Laurent Poirel; Sophie Marqué; Claire Héritier; Christine Segonds; Gérard Chabanon; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

5.  Extended -10 promoter in ISAba-1 upstream of blaOXA-23 from Acinetobacter baumannii.

Authors:  Heidi Segal; Rachael K Jacobson; Seike Garny; Colleen M Bamford; B Gay Elisha
Journal:  Antimicrob Agents Chemother       Date:  2007-06-04       Impact factor: 5.191

6.  Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii.

Authors:  Claire Héritier; Laurent Poirel; Pierre-Edouard Fournier; Jean-Michel Claverie; Didier Raoult; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

7.  Relative Strengths of Promoters Provided by Common Mobile Genetic Elements Associated with Resistance Gene Expression in Gram-Negative Bacteria.

Authors:  Muhammad Kamruzzaman; Jason D Patterson; Shereen Shoma; Andrew N Ginn; Sally R Partridge; Jonathan R Iredell
Journal:  Antimicrob Agents Chemother       Date:  2015-06-08       Impact factor: 5.191

8.  Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii.

Authors:  Claire Héritier; Laurent Poirel; Thierry Lambert; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

9.  Multidrug resistant acinetobacter.

Authors:  Vikas Manchanda; Sinha Sanchaita; Np Singh
Journal:  J Glob Infect Dis       Date:  2010-09

Review 10.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.